24 March 2025

Diabetes Obesity Pharmaceuticals

Why microdosing GLP-1s is not OK

24 March 2025

Clinical Diabetes Obesity PBAC TheHill

PBAC spurns tirzepatide for subsidy, again

10 March 2025

Diabetes Medicare Obesity Political

DoHAC targets GLP-1 docs

5 March 2025

Clinical Obesity

The Lancet Commission: Redefining obesity in general practice

4 March 2025

Obesity RACGP

Obesity is complex, so fund it that way

31 January 2025

Clinical Obesity

Coming up: New diagnostic criteria for obesity

21 January 2025

Cardiology Diabetes Pharmaceuticals

What Ozempic is and isn’t good for

15 January 2025

Obesity Research

It’s official: BMI should take backseat in obesity diagnosis

12 December 2024

AIHW Obesity Public Health Smoking

Smoking overtaken as No 1 contributor to disease burden

5 December 2024

Clinical Diabetes Obesity

Even more things GLP-1 RAs can do

5 December 2024

Clinical Obesity Pharmaceuticals

Why semaglutide doesn’t work for everyone

14 November 2024

Clinical Diabetes Obesity

Tirzepatide safe, highly effective for three years

23 October 2024

Clinical Obesity Sleep Sleep apnoea

Coming up: Sleep disorders and weight management

14 October 2024

Clinical Dermatology Hidradenitis Suppurativa

Semaglutide offers hope for rare skin disease

10 October 2024

Cancer Obesity

Obesity raises risk of second cancers in survivors

8 October 2024

Clinical Obesity Pregnancy

Obesity in pregnancy doubles risk for autism